vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and EPAM Systems (EPAM). Click either name above to swap in a different company.

EPAM Systems is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.1× Alignment Healthcare, Inc.). EPAM Systems runs the higher net margin — 7.8% vs 0.9%, a 6.8% gap on every dollar of revenue. On growth, EPAM Systems posted the faster year-over-year revenue change (12.8% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 9.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.

ALHC vs EPAM — Head-to-Head

Bigger by revenue
EPAM
EPAM
1.1× larger
EPAM
$1.4B
$1.2B
ALHC
Growing faster (revenue YoY)
EPAM
EPAM
+87.5% gap
EPAM
12.8%
-74.7%
ALHC
Higher net margin
EPAM
EPAM
6.8% more per $
EPAM
7.8%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
9.9%
EPAM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
EPAM
EPAM
Revenue
$1.2B
$1.4B
Net Profit
$11.4M
$109.4M
Gross Margin
30.1%
Operating Margin
10.6%
Net Margin
0.9%
7.8%
Revenue YoY
-74.7%
12.8%
Net Profit YoY
5.9%
EPS (diluted)
$1.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
EPAM
EPAM
Q1 26
$1.2B
Q4 25
$1.0B
$1.4B
Q3 25
$993.7M
$1.4B
Q2 25
$1.0B
$1.4B
Q1 25
$926.9M
$1.3B
Q4 24
$701.2M
$1.2B
Q3 24
$692.4M
$1.2B
Q2 24
$681.3M
$1.1B
Net Profit
ALHC
ALHC
EPAM
EPAM
Q1 26
$11.4M
Q4 25
$-11.0M
$109.4M
Q3 25
$3.7M
$106.8M
Q2 25
$15.7M
$88.0M
Q1 25
$-9.1M
$73.5M
Q4 24
$-31.1M
$103.3M
Q3 24
$-26.4M
$136.3M
Q2 24
$-24.0M
$98.6M
Gross Margin
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
30.1%
Q3 25
29.5%
Q2 25
28.8%
Q1 25
26.9%
Q4 24
30.4%
Q3 24
34.6%
Q2 24
29.3%
Operating Margin
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
-1.0%
10.6%
Q3 25
0.8%
10.4%
Q2 25
2.2%
9.3%
Q1 25
-0.6%
7.6%
Q4 24
-3.2%
10.9%
Q3 24
-2.8%
15.2%
Q2 24
-2.7%
10.5%
Net Margin
ALHC
ALHC
EPAM
EPAM
Q1 26
0.9%
Q4 25
-1.1%
7.8%
Q3 25
0.4%
7.7%
Q2 25
1.5%
6.5%
Q1 25
-1.0%
5.6%
Q4 24
-4.4%
8.3%
Q3 24
-3.8%
11.7%
Q2 24
-3.5%
8.6%
EPS (diluted)
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
$-0.04
$1.97
Q3 25
$0.02
$1.91
Q2 25
$0.07
$1.56
Q1 25
$-0.05
$1.28
Q4 24
$-0.15
$1.80
Q3 24
$-0.14
$2.37
Q2 24
$-0.13
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
EPAM
EPAM
Cash + ST InvestmentsLiquidity on hand
$705.6M
$1.3B
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$3.7B
Total Assets
$1.3B
$4.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
EPAM
EPAM
Q1 26
$705.6M
Q4 25
$604.2M
$1.3B
Q3 25
$644.1M
$1.2B
Q2 25
$503.8M
$1.0B
Q1 25
$479.5M
$1.2B
Q4 24
$470.6M
$1.3B
Q3 24
$381.0M
$2.1B
Q2 24
$363.7M
$1.8B
Total Debt
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
EPAM
EPAM
Q1 26
$206.9M
Q4 25
$179.3M
$3.7B
Q3 25
$161.9M
$3.7B
Q2 25
$141.0M
$3.7B
Q1 25
$108.1M
$3.6B
Q4 24
$99.9M
$3.6B
Q3 24
$114.5M
$3.6B
Q2 24
$123.7M
$3.4B
Total Assets
ALHC
ALHC
EPAM
EPAM
Q1 26
$1.3B
Q4 25
$1.1B
$4.9B
Q3 25
$1.1B
$4.8B
Q2 25
$1.0B
$4.7B
Q1 25
$895.6M
$4.7B
Q4 24
$782.1M
$4.8B
Q3 24
$692.3M
$4.5B
Q2 24
$716.3M
$4.2B
Debt / Equity
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
EPAM
EPAM
Operating Cash FlowLast quarter
$128.7M
$282.9M
Free Cash FlowOCF − Capex
$268.1M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
11.27×
2.59×
TTM Free Cash FlowTrailing 4 quarters
$612.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
EPAM
EPAM
Q1 26
$128.7M
Q4 25
$-50.4M
$282.9M
Q3 25
$144.6M
$294.7M
Q2 25
$29.1M
$53.2M
Q1 25
$16.6M
$24.2M
Q4 24
$-8.7M
$130.3M
Q3 24
$26.2M
$242.0M
Q2 24
$23.5M
$57.0M
Free Cash Flow
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
$-55.4M
$268.1M
Q3 25
$139.1M
$286.4M
Q2 25
$21.1M
$43.4M
Q1 25
$8.4M
$14.8M
Q4 24
$-18.0M
$114.5M
Q3 24
$16.9M
$237.0M
Q2 24
$11.8M
$52.3M
FCF Margin
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
-5.5%
19.0%
Q3 25
14.0%
20.5%
Q2 25
2.1%
3.2%
Q1 25
0.9%
1.1%
Q4 24
-2.6%
9.2%
Q3 24
2.4%
20.3%
Q2 24
1.7%
4.6%
Capex Intensity
ALHC
ALHC
EPAM
EPAM
Q1 26
Q4 25
0.5%
1.1%
Q3 25
0.6%
0.6%
Q2 25
0.8%
0.7%
Q1 25
0.9%
0.7%
Q4 24
1.3%
1.3%
Q3 24
1.3%
0.4%
Q2 24
1.7%
0.4%
Cash Conversion
ALHC
ALHC
EPAM
EPAM
Q1 26
11.27×
Q4 25
2.59×
Q3 25
38.77×
2.76×
Q2 25
1.86×
0.60×
Q1 25
0.33×
Q4 24
1.26×
Q3 24
1.77×
Q2 24
0.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons